ZBTB41: A Protein Implicated in Cell-Cell Adhesion and Cell Survival

Target Name: ZBTB41

NCBI ID: G360023

ZBTB41

ZBTB41: A Protein Implicated in Cell-Cell Adhesion and Cell Survival

ZBTB41 (ZBTB41 variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the ZBTB family of proteins, which are known for their role in cell-cell adhesion and survival signaling. ZBTB41 has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The ZBTB family of proteins was first identified in the 1990s by researchers who found that many proteins that were expressed in neural tissues, such as brain and kidney cells, had similar patterns of expression. These proteins were later shown to be involved in a variety of cellular processes, including cell adhesion, migration, and survival. The ZBTB family of proteins includes several different variants, including ZBTB41, ZBTB42, ZBTB43, and ZBTB44.

ZBTB41 is a 21-kDa protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the ZBTB family of proteins, which are known for their role in cell-cell adhesion and survival signaling. ZBTB41 has been shown to be involved in a variety of cellular processes, including cell adhesion, migration, and survival.

One of the key functions of ZBTB41 is its role in cell-cell adhesion. ZBTB41 is a member of the cadherin subfamily of transmembrane proteins, which are involved in cell-cell adhesion and migration. These proteins help to regulate the movement of cells along the body's surface and ensure that they stick to each other to form tissues and organs.

In addition to its role in cell-cell adhesion, ZBTB41 is also involved in the regulation of cell survival. This is done through its role in the stress response, which is a critical process that helps cells to adapt to and survive in a variety of environments. ZBTB41 has been shown to be involved in the regulation of cell stress responses, including the stress-induced apoptosis (ASD) pathway.

ZBTB41 has also been identified as a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that ZBTB41 is overexpressed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that targeting ZBTB41 with drugs or other therapeutic agents may be a promising strategy for the treatment of these cancers.

In addition to its potential as a drug target or biomarker, ZBTB41 is also of interest as a potential therapeutic agent for a variety of other conditions. For example, studies have shown that ZBTB41 can be used to reduce the migration of cancer cells in a variety of settings, including in culture and in animal models of cancer. This suggests that ZBTB41 may be an effective agent for the treatment of cancer by inhibiting cell migration and promoting cell differentiation.

Overall, ZBTB41 is a protein that is expressed in various tissues of the body and is involved in a variety of cellular processes, including cell adhesion, migration, and survival. Its potential as a drug target or biomarker for various diseases makes it an attractive target for further research and development. Further studies are needed to fully understand the role of ZBTB41 in cell biology and its potential as a therapeutic agent.

Protein Name: Zinc Finger And BTB Domain Containing 41

Functions: May be involved in transcriptional regulation

The "ZBTB41 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBTB41 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets